Lilly chops 50 jobs at ImClone after merger
Fifty of ImClone Systems Inc.’s 1,280 employees have been laid off just two weeks after Eli Lilly and Co. closed its acquisition of the New York cancer drug developer, according to New Jersey Business. Nearly half of ImClone’s 70 sales people were eliminated. Most were focused on ImClone’s main drug, Erbitux. Indianapolis-based Lilly paid $70 […]